Search

Search Constraints

You searched for: Author/Creator Mi, Sha

Search Results

3. Blocking LINGO-1 in vivo reduces degeneration and enhances regeneration of the optic nerve. (4th April 2016)

4. Functional activity of anti-LINGO-1 antibody opicinumab requires target engagement at a secondary binding site. Issue 1 (1st January 2020)

9. Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial. Issue 9 (September 2019)